Therefore, it is likely that, in addition to promoting cell survival through NF-κB signaling, MALT1 overexpression may enhance the capacity and scope of cell adhesion to prevent BTKi-induced lymphocytosis and tumor cell killing and thus confer BTKi resistance and immune evasion. Here, NFKB1 is linked to neoplasm.